Recruiting
Cadonilimab and Lenvatinib for Conversion Therapy in Unresectable Hepatocellular Carcinoma
NCT06215651
- Conditions
- Cadonilimab and Lenvatinib
- Locations
-
- Hai-Tao Zhao Beijing, Beijing Municipality, China